ArticleJournal of the American Academy of Dermatology2020
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.
Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04898166 (Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19)
Who cites it
25 citing papers in PubMed, 51 citations in OpenAlex.
- Recent Advances in the Role of Fibroblast Growth Factors in Hair Follicle Growth.Biomolecules · 2025Review
- Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case-Control Study.Aesthetic plastic surgery · 2025Observational
- Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19.Regenerative therapy · 2023Article
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.BMC pharmacology & toxicology · 2023Article
- Association of androgenetic alopecia with a more severe form of COVID-19 infection.Irish journal of medical science · 2023Observational
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19.Journal of clinical medicine · 2022Article
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies.International journal of molecular sciences · 2022Review
- Roles of steroid receptors in the lung and COVID-19.Essays in biochemistry · 2021Review
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID-19.Skin health and disease · 2021Article
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.Journal of cosmetic dermatology · 2021Review
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.EClinicalMedicine · 2021Article
- Clinical Patterns and Morphology of COVID-19 Dermatology.Dermatologic clinics · 2021Review
- Extraordinary claims without extraordinary evidence: controversy on anti-androgen therapy for COVID-19.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.Dermatologic therapy · 2021Review
- Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.European journal of endocrinology · 2021Article
- Article
- Androgens, the kidney, and COVID-19: an opportunity for translational research.American journal of physiology. Renal physiology · 2021Article
- Article
- Article
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial.Frontiers in medicine · 2021Article
Corrections and comments
- Comment on
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.